2026 HFM CME Symposium - Implications and Best Management of Hyperkalemia in Heart Failure

By: PRLog
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
This CME Symposium takes place on Saturday, July 18, 2026, from 8:00 - 9:00 AM PT during the 2026 Heart Failure Management Conference in Fernandina Beach, Florida.

HAZLET, N.J. - June 30, 2026 - PRLog -- In this symposium, a multidisciplinary expert faculty will describe best practices for prevention and treatment of hyperkalemia, enabling HF patients to continue and optimize guideline-directed medical therapies (GDMTs). A "real-world" case will emphasize to HF clinicians key messages and recommendations for clinical practice.

Click here for more information

CHAIR

Muthiah Vaduganathan, MD, MPH

Co-Director, Center for Cardiometabolic Implementation Science
Assistant Professor of Medicine
Mass General Brigham and Harvard Medical School
Boston, Massachusetts

FACULTY

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC

Associate Chief Nursing Officer--Research and Innovation
Clinical Nurse Specialist--Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Akshay Desai, MD, MPH
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Robert Page, PharmD, MSPH, BCPS, BCGP
Professor, Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado

Educational Objectives
  • Recognize heart failure patients at risk for developing hyperkalemia
  • Describe the relationship between hyperkalemia, suboptimal RAASi therapy and poor clinical outcomes
  • Explain the data with, and demonstrate prudent use of novel potassium binders

Target Audience
This program is intended for clinicians who manage patients with heart failure.

Educational Grant
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Contact
Voxmedia, LLC
***@voxmedia.us

Photos: (Click photo to enlarge)

Voxmedia Logo HFM CME Symposium


Source: CMEPlanet

Read Full Story - 2026 HFM CME Symposium - Implications and Best Management of Hyperkalemia in Heart Failure | More news from this source

Press release distribution by PRLog
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.70
+0.00 (0.00%)
AAPL  294.38
+0.00 (0.00%)
AMD  540.88
+0.00 (0.00%)
BAC  58.36
+0.00 (0.00%)
GOOG  357.89
+0.00 (0.00%)
META  612.91
+0.00 (0.00%)
MSFT  384.28
+0.00 (0.00%)
NVDA  197.58
+0.00 (0.00%)
ORCL  142.50
+0.00 (0.00%)
TSLA  425.30
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.